Company intelligence / Profile preview
Ningbo Xinwan Pharmaceutical Technology
Ningbo, Zhejiang, China
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has several small molecule programs targeting oncology and related disorders, with at least one program (NB004) in Phase 1 for locally advanced malignant solid neoplasms and additional programs at preclinical and discovery stages. Clinical results are not detailed in public sources, and four clinical trial entries are referenced without publicly released outcomes[3].
- Therapeutic areas
- OncologyDermatologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Ningbo Xinwan Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ningbo Xinwan Pharmaceutical Technology.